Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ

Revenue (LTM)

Net Income (LTM)

$-79M

-95.3% YoY

Free Cash Flow

$-64M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	0	0	0	0
Gross Profit	-1	-1↓96.4%	0	-1	-0↑61.2%
Operating Income	-56	-35↑37.8%	-45↓29.4%	-49↓8.1%	-85↓75.1%
Net Income	-46	-56↓22.6%	-45↑20.1%	-40↑9.9%	-79↓95.3%
EBITDA	-54	-39↑28.7%	-40↓3.6%	-38↑5.9%	-85↓125.4%
EPS Diluted	-11.11	-10.15↑8.6%	-10.31↓1.6%	-3.68↑64.3%	-5.90↓60.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	25	17↓32.0%	14↓19.3%	17↑25.3%	28↑65.7%
Total Current Assets	100	60↓39.9%	24↓60.9%	153↑549.7%	167↑9.1%
Total Assets	108	66↓38.4%	28↓57.4%	156↑451.4%	168↑7.9%
Total Current Liabilities	17	13↓25.7%	32↑152.3%	12↓62.9%	21↑75.1%
Total Liabilities	39	33↓13.7%	35↑5.6%	13↓61.8%	21↑53.8%
Total Equity	69	33↓52.3%	-7↓120.9%	142↑2162.7%	148↑3.6%
Total Debt	27	25↓5.6%	21↓16.8%	3↓84.5%	2↓49.6%
Net Debt	2	8↑410.5%	7↓11.4%	-14↓294.9%	-27↓92.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-48	-38↑22.1%	-36↑3.8%	-42↓15.8%	-64↓54.3%
Capital Expenditure	-0	-0↑75.2%	0↑100.0%	0	-0
Free Cash Flow	-48	-38↑22.1%	-36↑3.9%	-42↓15.8%	-64↓54.3%
Stock-Based Comp	9	6↓39.7%	0	6	6↑2.3%
Net Change in Cash	-61	-8↑86.8%	-3↑59.0%	3↑205.9%	11↑225.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance